| Literature DB >> 27441839 |
V Chaumeau1,2,3, C Andolina4, B Fustec2,3, N Tuikue Ndam5,6, C Brengues2, S Herder7,8, D Cerqueira3,4, T Chareonviriyaphap9, F Nosten4,10, V Corbel2,3,9.
Abstract
Quantitative real-time polymerase chain reaction (qrtPCR) has made a significant improvement for the detection of Plasmodium in anopheline vectors. A wide variety of primers has been used in different assays, mostly adapted from molecular diagnosis of malaria in human. However, such an adaptation can impact the sensitivity of the PCR. Therefore we compared the sensitivity of five primer sets with different molecular targets on blood stages, sporozoites and oocysts standards of Plasmodium falciparum (Pf) and P. vivax (Pv). Dilution series of standard DNA were used to discriminate between methods at low concentrations of parasite and to generate standard curves suitable for the absolute quantification of Plasmodium sporozoites. Our results showed that the best primers to detect blood stages were not necessarily the best ones to detect sporozoites. Absolute detection threshold of our qrtPCR assay varied between 3.6 and 360 Pv sporozoites and between 6 and 600 Pf sporozoites per mosquito according to the primer set used in the reaction mix. In this paper, we discuss the general performance of each primer set and highlight the need to use efficient detection methods for transmission studies.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27441839 PMCID: PMC4956213 DOI: 10.1371/journal.pone.0159160
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sequences of the primers used in the study and corresponding references.
| Primer set | Ref. | Name | Sequence | PCR DNA target | Target species |
|---|---|---|---|---|---|
| I | [ | Forward | 5’-TAGCCGACAAGGAATTTTGC-3’ | ncMS | Pspp |
| Reverse | 5’-CCTTGAATGGAGCACTGGAT-3’ | ||||
| II | [ | Pf1 | 5’-CCTGCATTAACATCATTATATGGTACATCT-3’ | COX I | Pf |
| Pf2 | 5’-GATTAACATTCTTGATGAAGTAATGATAATACCTT-3’ | ||||
| Pv1 | 5’-AAGTGTTGTATGGGCTCATCATATG-3’ | COX III | Pv | ||
| Pv2 | 5’-CAAAATGGAAATGAGCGATTACAT-3’ | ||||
| III | [ | Pspp1 | 5'-AGTTACGATI'AATAGGAGTAG-3’ | 18S ssuRNA genes | Pspp |
| Pspp2 | 5'-CCAAAGACTI'TGATTTCTCAT-3' | ||||
| IV | [ | PL1473F18 | 5’-TAACGAACGAGATCT TAA-3’ | 18S ssuRNA genes | Pspp |
| PL1679R18 | 5’-GTTCCTCTAAGAAGCTTT-3’ | ||||
| V | [ | FAL-F | 5’-CTTTTGAGAGGTTTTGTTACTTTGAGTAA-3’ | 18S ssuRNA genes | Pf |
| FAL-R | 5’-TATTCCATGCTGTAGTATTCAAACACAA-3’ | ||||
| VIV-F | 5’-ACGCTTCTAGCTTAATCCACATAACT-3’ | 18S ssuRNA genes | Pv | ||
| VIV-R | 5’-ATTTACTCAAAGTAACAAGGACTTCCAAGC-3’ |
Ref., reference; ncMS, non-coding mitochondrial sequence; COX, cyclo-oxygenase; Pf, Plasmodium falciparum; Pspp, Plasmodium spp.; Pv, Plasmodium vivax.
* identification of the plasmodial species is possible through the melt-curve analysis of the PCR product.
Fig 1Typical amplification curves, melt curves and standard curves generated with the five primer sets.
(A,B,E,F and I) Amplification curves generated by the real-time measurement of the fluorescent signal at the end of each amplification cycle; (C,D,G,H, and K) Melt curves analysis of the PCR product; (J and L) Amplification curves and standard curve generated during the assessment of primer set II on dilution series of calibrated Plasmodium vivax sporozoites standard (vial 1), demonstrating the linear relationship between the logarithm of the parasitic concentration and the CP value. Brown and green lines represent Plasmodium falciparum and Plasmodium vivax standards respectively; blue lines represent the non-template negative control.
Optimal reaction conditions and corresponding efficiencies using the CFX-96® (Biorad) device.
| Primer set | Annealing temperature (°C) | MgCl2 concentration (mM) | Primers concentration (nM) | %EFF | %EFF |
|---|---|---|---|---|---|
| I | 58 | 2.5 | 250 each | ND | 110 |
| II | 60 | 2.5 | 300 each | 84 | 92 |
| III | 58 | 2.5 | 500 each | 96 | 110 |
| IV | 54 | 2.5 | 250 each | 97 | 101 |
| V | 60 | 2.5 | 400 each | ND | ND |
ND, not determined; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; EFF, efficiency of the PCR.
a %EFF: efficiency (EFF) of the PCR calculated with the formula EFF = 10(-1/slope) - 1 and expressed as a percentage. An efficiency of 100% corresponds to a slope of -3.32 and means that the number of amplicons doubles after each cycle of amplification. Efficiency was calculated from serial dilutions of calibrated Pf and Pv sporozoite standards.
b Due to the lack of sample, it was not possible to determine the PCR efficiency of the primer pair I with the Pf sporozoite standard.
c Due to the presence of primer-dimers, it was not possible to determine the PCR efficiency with primer set V.
Results of the assessment of each primer set on sporozoites, oocysts and blood stages standards.
| Standard sample | Species | Primer set | Dilution | Score | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ND | 10−1 | 10−2 | 10−3 | 10−4 | 10−5 | 10−6 | 10−7 | 10−8 | 10−9 | nb | % | |||||||||||||
| nb | %a | nb | % | Nb | % | nb | % | nb | % | nb | % | nb | % | nb | % | nb | % | nb | % | |||||
| Head/Thorax (sporozoites) | Pf | I | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 36/48 | 75 | ||||||||
| II | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 36/48 | 75 | ||||||||||
| III | 12/12 | 100 | 12/12 | 100 | 11/12 | 92 | - | - | - | - | - | - | 22/48 | 46 | ||||||||||
| IV | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 25/48 | 52 | ||||||||||
| V | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 12/48 | 25 | ||||||||||
| Pv | I | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | - | - | - | - | 23/36 | 64 | |||||||
| II | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | - | - | - | - | 18/36 | 50 | ||||||||
| III | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | - | - | - | - | 10/36 | 28 | ||||||||
| IV | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | - | - | - | - | 11/36 | 31 | ||||||||
| V | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | 0/12 | 0 | - | - | - | - | 0/36 | 0 | ||||||||
| Abdomen (oocysts) | Pf | I | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 25/48 | 52 | ||||||||
| II | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 24/48 | 50 | ||||||||||
| III | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 13/48 | 27 | ||||||||||
| IV | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | - | - | 13/48 | 27 | ||||||||||
| V | 12/12 | 100 | 12/12 | 100 | 10/12 | 83 | - | - | - | - | - | - | 0/48 | 0 | ||||||||||
| Pv | I | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 26/60 | 43 | |||||||||||
| II | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 35/60 | 58 | ||||||||||||
| III | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 12/60 | 20 | ||||||||||||
| IV | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 17/60 | 28 | ||||||||||||
| V | 12/12 | 100 | 11/12 | 92 | 0/12 | 0 | - | - | - | - | 0/60 | 0 | ||||||||||||
| Blood (blood stages) | Pf | I | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 25/48 | 52 | ||||||||
| II | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 26/48 | 54 | ||||||||||
| III | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 9/48 | 19 | ||||||||||
| IV | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | - | - | - | - | 11/48 | 23 | ||||||||||
| V | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 10/12 | 83 | - | - | - | - | 1/48 | 2 | ||||||||||
| Pv | I | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | 12/36 | 33 | |||||||
| II | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | 17/36 | 47 | ||||||||
| III | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | 12/36 | 33 | ||||||||
| IV | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | 19/36 | 53 | ||||||||
| V | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 12/12 | 100 | 0/12 | 0 | 0/12 | 0 | 0/36 | 0 | ||||||||
ND, not diluted; Pf, Plasmodium falciparum; Pv, Plasmodium vivax.
a number (nb) or percentage (%) of positive reactions over the total number of reaction performed.
b score of the proportion of positive reactions at low concentrations of parasite (the bold cells indicate the concentrations used to calculate the score), the definition is given in the section Material and Methods; an example of the calculation of the score is given here: the maximum hit for the score on Plasmodium vivax sporozoites standard is 48 reactions (12 at the dilution D, +12 at the dilution E, +12 at the dilution F and +12 at the dilution G), the score obtained with the primer pair I is 75% (36/48 = (12+12+10+2)/48).
Results of the assessment of each primer set on calibrated standards of Plasmodium vivax sporozoites.
| Primer set (%EFF and r2) | Parameter | Value at the indicated concentration (in Pvg equivalent per tube) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 9,000 | 900 | 90 | 9 | 0.9 | 0.1 | 0.01 | 0.001 | ||
| I (110%, 0.997) | Nb. Positive (%) | 5/9 (56%) | 0/9 | 0/9 | |||||
| Mean CP value | 31.90 | - | - | ||||||
| Intra-SD | 0.23 | - | - | ||||||
| Inter-SD | 0.22 | - | - | ||||||
| II (92%, 0.999) | Nb. Positive | 1/9 (11%) | 0/9 | ||||||
| Mean CP value | - | - | |||||||
| Intra-SD | - | - | |||||||
| Inter-SD | - | - | |||||||
| III (110%, 0.991) | Nb. positive | 3/9 (33%) | 0/9 | 0/9 | |||||
| Mean CP value | 37.56 | - | - | ||||||
| Intra-SD | 0.35 | - | - | ||||||
| Inter-SD | 0.56 | - | - | ||||||
| IV (101%, 0.999) | Nb. positive | 2/9 (22%) | 1/9 (11%) | 0/9 | |||||
| Mean CP value | 35.86 | 35.83 | - | ||||||
| Intra-SD | - | - | - | ||||||
| Inter-SD | 1.52 | - | - | ||||||
| V | Nb. positive | 9/9 (100%) | 9/9 (100%) | 9/9 (100%) | 9/9 (100%) | 1/9 (11%) | 0/9 | 0/9 | 0/9 |
| Mean CP value | - | - | - | - | - | - | - | - | |
| Intra-SD | - | - | - | - | - | - | - | - | |
| Inter-SD | - | - | - | - | - | - | - | - | |
a %EFF: efficiency (EFF) of the PCR was calculated with the formula EFF = 10(-1/slope) - 1 and expressed as a percentage. An efficiency of 100% corresponds to a slope of -3.32 and means that the number of amplicons doubles after each cycle of amplification; r2: Pearson’s correlation coefficient expressing the intensity of the relationship between the logarithm of the concentration and the mean CP value. r2 varies between 0 (no correlation) and 1 (perfect correlation), a value >0.990 testify of the linearity of the method (over a defined linear range) and allow an accurate quantification. r2 and EFF have been calculated on the linear dynamic of each curve (bold cells).
b Nb. Positive (%): number of positive reactions (amplification of the PCR DNA target) / total of reactions performed at a given dilution and corresponding percentage.
c Intra-assay SD: intra-assay standard deviation (SD), calculated as the average SD of the mean CP value measured for each dilution during the same experiment.
d Inter-assay SD: inter-assay standard deviation (SD), calculated as the SD of the means CP values measured during two independent experiments.
* co-amplification of primer-dimers during the PCR invalidates the calculation of the CP values and the estimation of the subsequent parameters of the best-fit line.
Results of the assessment of each primer set on calibrated standards of Plasmodium falciparum sporozoites.
| Primer set (%EFF and r2) | Parameter | Value at the indicated concentration (in Pfg equivalent per tube) | ||||||
|---|---|---|---|---|---|---|---|---|
| 1500 | 150 | 15 | 1.5 | 0.15 | 0.015 | 0.002 | ||
| I | Nb. Positive (%) | - | - | - | - | - | - | - |
| Mean CP value | - | - | - | - | - | - | - | |
| Intra-SD | - | - | - | - | - | - | - | |
| Inter-SD | - | - | - | - | - | - | - | |
| II (84%, 0.998) | Nb. Positive | 2/9 (22%) | 0/9 (0%) | |||||
| Mean CP value | 38.99 | - | ||||||
| Intra-SD | - | - | ||||||
| Inter-SD | 0.40 | - | ||||||
| III (96%, 0.996) | Nb. positive | 0/9 (0%) | 0/9 (0%) | |||||
| Mean CP value | - | - | ||||||
| Intra-SD | - | - | ||||||
| Inter-SD | - | - | ||||||
| IV (97%, 0.991) | Nb. positive | 0/9 (0%) | 0/9 (0%) | |||||
| Mean CP value | - | - | ||||||
| Intra-SD | - | - | ||||||
| Inter-SD | - | - | ||||||
| V | Nb. positive | 9/9 (100%) | 9/9 (100%) | 9/9 (100%) | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| Mean CP value | - | - | - | - | - | - | - | |
| Intra-SD | - | - | - | - | - | - | - | |
| Inter-SD | - | - | - | - | - | - | - | |
a %EFF: efficiency (EFF) of the PCR was calculated with the formula EFF = 10(-1/slope) - 1 and expressed as a percentage. An efficiency of 100% corresponds to a slope of -3.32 and means that the number of amplicons doubles after each cycle of amplification; r2: Pearson’s correlation coefficient expressing the intensity of the relationship between the logarithm of the concentration and the mean CP value. r2 varies between 0 (no correlation) and 1 (perfect correlation), a value >0.990 testify of the linearity of the method (over a defined linear range) and allow an accurate quantification. r2 and EFF have been calculated on the linear dynamic of each curve (bold cells).
b Nb. Positive (%): number of positive reactions (amplification of the PCR DNA target) / total of reactions performed at a given dilution and corresponding percentage.
c Intra-assay SD: intra-assay standard deviation (SD), calculated as the average SD of the mean CP value measured for each dilution during the same experiment.
d Inter-assay SD: inter-assay standard deviation (SD), calculated as the SD of the means CP values measured during two independent experiments.
* due to the lack of sample, it was not possible to perform the experiment with the primer pair I.
** co-amplification of primer-dimers during the PCR invalidates the calculation of the CP values and the estimation of the subsequent parameters of the best-fit line.
Determination of the limit of detection (LOD) using calibrated standards of Pf and Pv sporozoites.
| Primer set | LOD for the indicated species | |
|---|---|---|
| Pf | Pv | |
| I | ND | 0.1 (3.6) |
| II | 0.15 (6) | 0.1 (3.6) |
| III | 1.5 (60) | 0.9 (36) |
| IV | 1.5 (60) | 0.9 (36) |
| V | 15 (600) | 9 (360) |
LOD, limit of detection; ND, not determined; Pf, Plasmodium falciparum; Pv, Plasmodium vivax.
a limits of detection are expressed in number of Plasmodium falciparum and Plasmodium vivax genome equivalent (Pfg and Pvg) per reaction tube, values into brackets represent the corresponding number of sporozoites per mosquito.
b due to the lack of sample, it was not possible to determine the LOD of the primer pair I for Pf sporozoites. According to the score values presented in the Table 3, the LOD determined with the primer pair I should be similar to the LOD determined with the primer set II for Pf sporozoites (6 Pf sporozoites per mosquito).
Descriptive statistic of the sporozoite loads in naturally infected Anopheles collected along the Thai-Myanmar border.
| Species | Value for the indicated species | ||||
|---|---|---|---|---|---|
| Nb. infected specimen | geometric mean [CI95%] | minimum | maximum | median | |
| Pf | 12 | 57[52–60] | 9 | 11,428 | 28 |
| Pv | 37 | 137 [132–141] | <36 | 273,787 | 71 |
CI, confidence interval; Pf, Plasmodium falciparum; Pv, Plasmodium vivax.
a Nb. infected specimen: number of Anopheles naturally infected with Plasmodium.
b Geometric mean, minimum, maximum and median of the sporozoite load in Anopheles naturally infected with Plasmodium, expressed in number of sporozoites per mosquito.
Fig 2Frequency distribution of the sporozoite loads in naturally infected Anopheles collected along the Thai-Myanmar border.
The sporozoite loads in the studied area are very low: 60% (30/49) of the infected Anopheles carry less than 100 sporozoites.